ArticleJournal of pharmaceutical health care and sciences2022

A case report involving suppressed nuclear receptor transcription factors 4a1 and Stevens-Johnson syndrome induced by a single dose of pembrolizumab and successfully treated with early steroid administration, resulting in complete remission of stage III lung cancer.

Maiko Machida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.